Mckesson Medical-Surgical Inc. Corporate Office recalls Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for:…

Recall date

April 25, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0400-2025

FDA classification

Class II

Brand / firm

Mckesson Medical-Surgical Inc. Corporate Office

Sold / distributed

Distributed to Medical Facilities in MS and FL.

Why it was recalled

Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01